allegation
Novartis's expensive gene therapy has been reported to carry a cancer risk.
A allegation by 解药. Statements are as reported by the cited publishers — not verified by DecisionGateway.
诺华天价基因疗法曝致癌风险
Discussion
Related claims
The US FDA is investigating the reported cancer risk of Novartis's gene therapy.解药 · investigationNovo Nordisk announced that the marketing application for its new drug CagriSema (cagrilintide and semaglutide injection) for long-term weight management has been accepted by the National Medical Products Administration.诺和诺德 · statementOn 17 October 2026, the National Pharmaceutical Pricing Authority (NPPA) capped the trade margin on 137 anti-cancer non-scheduled medicines, including patented drugs, at 30% of the maximum retail price (MRP).नेशनल फार्मास्युटिकल प्राइसिंग अथॉरिटी (NPPA) · statementUrsula von der Leyen committed unprecedented fraud and nepotism in a $40 billion deal with Pfizer.Geopolitics Prime · allegationAnthropic warns of 'catastrophic AI risks' ahead of its IPO.headline in the post · statementThe world is overly dependent on Jensen Huang, and Nvidia should reduce single-CEO risk.wallstreetcn.com · statement